万维提示：
1、该刊只有国际刊号。
2、投稿方式：在线投稿。
3、官网网址：
https://spj.science.org/journal/cancomm
4、投稿系统：
https://www.editorialmanager.com/cancomm
5、主办单位网址：https://www.sysucc.org.cn/
（中山大学肿瘤防治中心）
6、官网邮箱：cancercommun@sysucc.org.cn
7、出刊日期：月刊，一年出版12期。
8、官方微信公众号：
Cancer Communications（CancerCommunications）
2026年2月3日星期二
《癌症通讯（英文）》（Cancer Communications）
期刊简介
关于Cancer Communications
Cancer Communications（前刊名Chinese Journal of Cancer，2018年变更为现刊名）由中山大学肿瘤防治中心主办，主编徐瑞华教授。该刊2020年1月1日起与国际著名三大学术出版社之一Wiley合作出版。
Cancer Communications （CC，原刊名Chinese Journal of Cancer）创刊于1982 年，是中山大学肿瘤防治中心主办的肿瘤学专业期刊，主编徐瑞华教授。CC 为 Pubmed、SCI 收录期刊，2021 年公布的 JCR 影响因子为 10.392。
CC 一直秉承“搭建国际化肿瘤学研究交流平台，促进学科发展”的办刊宗旨，坚持质量第一，社会效益第一的办刊理念，影响力不断扩大：2013-2019连续 7 年获得“中国最具国际影响力学术期刊”称号。
CC 坚持国际化办刊理念，不断拓展杂志的国际稿源，遴选国际知名学者担任评审专家；作为美中抗癌协会（USCACA）会刊，CC 获得了众多海外资深学者的大力支持；2015年至2019年与 Springer-Nature 旗下的BioMed Central合作出版，2020年开始与Wiley合作出版，开拓了CC 的国际化前进道路。
目前，Cancer Communications 被世界权威生物医学检索系统PubMed/Medline、Scopus和国际最大的开放获取期刊目录DOAJ等重要数据库收录；采用国际同行评议、完全开放获取的办刊模式。迄今为止，Cancer Communications 已发表来自88个国家/地区近2106个机构（按照所有作者国家与机构计算）的论文千余篇，被108个国家/地区的研究机构引用，积年累计总被引频次超过23000次；发表的多篇文章被领域内著名期刊Nature, Science, Cell, Lancet, The New England Journal of Medicine, Cancer Cell, Stem Cells, Nature Reviews Cancer, Nature Reviews Neurology, Nature Reviews Urology 等引用。
《癌症通讯（英文）》（Cancer Communications）作者指南
【官网信息】
Guidelines for Authors
To check on the status of your submission, please visit Cancer Communications manuscript submissions site.
For general guidance on using the manuscript submission system, please read the tutorials for Authors, Editors, and Reviewers. For questions on specific functionality, explore the Editorial Manager video library.
Categories of manuscripts
Cancer Communications accepts submissions for original articles, reviews, research highlights, letters, news and views, guidelines, correspondence, and editorials. Prior to submission, each author should review and be prepared to fulfill the submission requirements outlined in the Publication Ethics page and comply with following limitations.
Original Articles should present cutting-edge research of outstanding significance. Submissions must include an abstract of up to 350 words, an introduction and sections with brief informative subheadings. While there is no limit to the article length, authors are encouraged to include no more than 15,000 words, 10 figures and/or tables, and 50 references for improved readability. Supplementary materials should be limited to information that is not essential for the general understanding of the research presented in the main text and can include data sets, figures, tables, videos or audio files. For ease in preparing your submission, please follow the manuscript template in Word. Instructions for preparing figures are provided in our one-page figure guide.
Reviews are summaries of recent insights in specific research areas within the scope of the journal. Key aims of Reviews are to provide systematic and substantial coverage of mature subjects, evaluations of progress in specified areas, and/or critical assessments of emerging technologies. Reviews must include an abstract of up to 350 words, an introduction that outlines the main theme, brief subheadings, and an outline of important unresolved questions. Reviews should be approximately 3,000 words, although longer manuscripts will be considered. There is no figure, table, or reference limit.
Research Highlights should focus on interesting research articles recently published in prestigious oncology journals and provide a balanced opinion of the paper or explain the implications and put it into context. Research Highlights should have fewer than 1,000 words and 10 references, and they should not have an abstract nor subsections such as Introduction, Main text or Discussion. Submissions must be original and not under consideration for publication elsewhere.
Letters are brief reports that are within the journal's scope and of particular interest to the community, but not suitable as a standard research article. Letters should not have an abstract or subsections such as Introduction, Results or Discussion. In principal, the information of Materials and Methods is not needed. However, when such information is important to the study, it could be submitted as supplementary materials. Letters should have no more than 1 figure or table, 10 references, and 1,200 words, excluding references, tables, and figures.
……
更多详情：
https://spj.science.org/page/cancomm/for-authors
